Cefpodoxime Proxetil — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	PO	5-10 mg/kg	q12h	Duration: 5-7 days for skin infections; 10-14 days for UTI or respiratory infections Notes: Administer with food to enhance absorption. For pyoderma, continue treatment for 2-3 days beyond clinical resolution.
Cat	PO	5-10 mg/kg	q12h	Duration: 5-7 days for skin infections; 10-14 days for UTI or respiratory infections Notes: Administer with food. Use cautiously in cats with renal impairment.
Horse	PO	10 mg/kg	q12h	Duration: 5-7 days Notes: Not approved; oral absorption is variable. Use only if no alternative is available.
Cattle	PO	Not established	Not established	Duration: Not established Notes: Not recommended due to lack of data and withdrawal times.
Small Ruminants	PO	Not established	Not established	Duration: Not established Notes: Not recommended due to lack of data.
Rabbit	PO	Not established	Not established	Duration: Not established Notes: Not recommended due to lack of data.
Bird/Poultry	PO	Not established	Not established	Duration: Not established Notes: Not recommended due to lack of data and withdrawal times.
Exotic/Other	PO	Not established	Not established	Duration: Not established Notes: Use only with caution and based on extrapolation from other species.

Clinical Indications & Species Uses

General Indications

Treatment of infections caused by susceptible Gram-positive and Gram-negative bacteria, including skin, soft tissue, urinary tract, and respiratory tract infections.

Dog (Canine)

Treatment of skin infections (wounds, abscesses, pyoderma) caused by susceptible Staphylococcus spp. and Streptococcus spp.
Treatment of urinary tract infections caused by E. coli, Proteus mirabilis, and other susceptible organisms.
Treatment of respiratory tract infections (pneumonia, bronchitis) caused by susceptible organisms.

Cat (Feline)

Treatment of skin infections (wounds, abscesses) caused by susceptible organisms.
Treatment of urinary tract infections caused by susceptible organisms.
Treatment of respiratory tract infections (rhinitis, bronchitis) caused by susceptible organisms.

Pharmacology & Mechanism of Action

Drug Class: Third-generation cephalosporin antibiotic | Pharmacological Group: Beta-lactam antibiotic

Mechanism of Action: Cefpodoxime proxetil is a prodrug that is de-esterified by intestinal esterases to the active form, cefpodoxime. Cefpodoxime exerts its bactericidal effect by binding to penicillin-binding proteins (PBPs) in the bacterial cell wall, inhibiting peptidoglycan synthesis, and activating autolytic enzymes, leading to cell lysis. It is stable against many beta-lactamases, particularly those produced by Gram-negative bacteria, due to its aminothiazolyl side chain.

Pharmacodynamics: Cefpodoxime has a broad spectrum of activity against Gram-positive and Gram-negative bacteria. It is effective against many strains of Staphylococcus spp., Streptococcus spp., Escherichia coli, Pasteurella multocida, Proteus mirabilis, and Klebsiella spp. It has reduced activity against Pseudomonas aeruginosa and Enterococcus spp. Its bactericidal activity is time-dependent, and the post-antibiotic effect is minimal.

⚡ Pharmacokinetics Summary

Absorption: Cefpodoxime proxetil is well absorbed after oral administration in dogs and cats, with a bioavailability of approximately 50-80% when given with food. It is a prodrug that is hydrolyzed to active cefpodoxime in the intestinal wall.

Distribution: Cefpodoxime is widely distributed in body tissues and fluids, including skin, soft tissues, respiratory tract, and urinary tract. It crosses the blood-brain barrier poorly unless meninges are inflamed. Protein binding is low to moderate (about 20-30% in dogs).

Metabolism: Cefpodoxime proxetil is de-esterified to cefpodoxime during absorption. The active drug undergoes minimal hepatic metabolism.

Excretion: Cefpodoxime is primarily excreted unchanged in the urine via glomerular filtration and tubular secretion. A small amount is eliminated in bile and feces.

Half-Life: Dogs: approximately 4-5 hours; Cats: approximately 5-6 hours; Horses: approximately 2-3 hours.

Bioavailability: Oral bioavailability is approximately 50-80% in dogs and cats, with food enhancing absorption.

Protein Binding: Approximately 20-30% in dogs and cats.

Available Formulations & Strengths

Oral Tablet 100 mg, 200 mg (PO)

Oral Suspension (reconstituted) 50 mg/mL, 100 mg/mL (PO)

Contraindications & Clinical Warnings

Contraindications:

Known hypersensitivity to cefpodoxime or other cephalosporins
History of severe allergic reactions to penicillins (cross-reactivity possible)
Use in animals with severe renal impairment without dose adjustment

Warnings & Clinical Precautions:

Use with caution in animals with a history of gastrointestinal disease, especially colitis.
Prolonged use may result in overgrowth of non-susceptible organisms (e.g., Clostridium difficile).
Safety in pregnant or lactating animals has not been fully established; use only when clearly needed.
In food animals, extra-label use is prohibited in the US due to lack of withdrawal times.
Administer with food to reduce GI upset and enhance absorption.

Adverse Effects & Reactions

Common:

Vomiting
Diarrhea
Loss of appetite
Hypersalivation (especially in cats)

Serious / Severe:

Anaphylaxis
Clostridium difficile-associated diarrhea
Renal toxicity (rare)
Seizures (with high doses or renal impairment)

Rare:

Blood dyscrasias (neutropenia, thrombocytopenia)
Hepatotoxicity
Allergic skin reactions

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Probenecid	Probenecid decreases renal tubular secretion of cefpodoxime, increasing its plasma concentration and half-life.	Moderate
Aminoglycosides	Additive nephrotoxicity and potential synergistic antibacterial effect.	Moderate
Loop diuretics (e.g., furosemide)	May increase the risk of nephrotoxicity.	Mild
Antacids or H2 blockers	May reduce absorption of cefpodoxime proxetil by altering gastric pH.	Mild

Overdose & Toxicity Management

Signs of Toxicity:

Vomiting
Diarrhea
Anorexia
Neurological signs (e.g., tremors, seizures) in severe cases

Emergency Treatment Protocol: There is no specific antidote. Treatment is symptomatic and supportive. Induce vomiting if ingestion is recent and the animal is conscious. Administer activated charcoal to reduce absorption. Monitor for signs of dehydration and electrolyte imbalance. Provide fluid therapy and supportive care. In severe cases, consider hemodialysis or peritoneal dialysis to enhance elimination.

Food Animal Withdrawal Times

Cefpodoxime proxetil is not approved for use in food animals in the US. Extra-label use is prohibited in food animals due to lack of established withdrawal times. In other countries, if used, withdrawal times must be determined based on local regulations and pharmacokinetic data.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F), excursions permitted between 15-30°C (59-86°F).

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Protect from light and moisture. Keep in original container. Reconstituted oral suspension should be stored in refrigerator (2-8°C) and used within 14 days.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Approved for use in dogs and cats in the US (e.g., Simplicef® for dogs). Not approved for other species.

Extra-Label (Off-Label) Use: In the US, extra-label use of cefpodoxime proxetil in food animals is prohibited by the FDA due to lack of withdrawal times. In companion animals, extra-label use is permitted under AMDUCA, but requires a valid veterinarian-client-patient relationship and careful monitoring.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Cefpodoxime proxetil is a valuable third-generation cephalosporin for treating skin, urinary, and respiratory infections in dogs and cats. Its broad spectrum and beta-lactamase stability make it useful for infections caused by resistant organisms. Administer with food to improve absorption and reduce GI upset. Monitor renal function in animals with pre-existing renal disease. Use with caution in animals with a history of beta-lactam allergy. For food animals, avoid use due to regulatory restrictions. Always culture and sensitivity test when possible to ensure appropriate antibiotic selection.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)